A generic drug combination synergizes as exercise enhancers to ameliorate various metabolically-related diseases
RNA-seq (gene expression) · mouse · 28 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 28 samples: 28 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE255008_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1073195 and SRA study SRP488022. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 28 sample titles: 28 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8062475 D1_AB_L, 24h after A and B injection
- GSM8062476 D1_D_L, 24h after vehicle control injection
- GSM8062477 D1_AB_M, 24h after A and B injection
- GSM8062478 D1_D_M, 24h after vehicle control injection
- GSM8062479 L2_1, vehicle control for 40 days
- GSM8062480 L2_3, vehicle control for 40 days
- GSM8062481 L2_4, vehicle control for 40 days
- GSM8062482 L2_5, vehicle control for 40 days
- GSM8062483 L3_2, vehicle control for 40 days
- GSM8062484 L6_1, vehicle control for 40 days
- GSM8062485 L4_5, A and B treatment for 40 days
- GSM8062486 L5_1, A and B treatment for 40 days
- GSM8062487 L5_2, A and B treatment for 40 days
- GSM8062488 L5_3, A and B treatment for 40 days
- GSM8062489 L5_4, A and B treatment for 40 days
- GSM8062490 L5_5, A and B treatment for 40 days
- GSM8062491 M2_1, vehicle control for 40 days
- GSM8062492 M2_3, vehicle control for 40 days
- GSM8062493 M2_4, vehicle control for 40 days
- GSM8062494 M2_5, vehicle control for 40 days
- GSM8062495 M3_2, vehicle control for 40 days
- GSM8062496 M6_1, vehicle control for 40 days
- GSM8062497 M4_5, A and B treatment for 40 days
- GSM8062498 M5_1, A and B treatment for 40 days
- GSM8062499 M5_2, A and B treatment for 40 days
- GSM8062500 M5_3, A and B treatment for 40 days
- GSM8062501 M5_4, A and B treatment for 40 days
- GSM8062502 M5_5, A and B treatment for 40 days
- GSE311912 Probiotics Complex Synergizes with FOLFOX to Enhance Antitumor Response and Ameliorate Chemotherapy-induced Intestinal Toxicity via Upregulation of NAD+ Metabolism 27 samples shares synergizes, ameliorate
- GSE284500 Transcriptional profiling of hippocampus from a zQ175 KI mouse model of Huntington's disease treated with either HTT-10150 siRNA targeting full-length HTT or combination of HTT-634 and HTT-486 siRNAs targeting HTT1a 192 samples shares combination
- GSE342349 CT26 multi-tissue RNA-seq under immunotherapy combinations 72 samples shares combination
- GSE298240 Inhibition of p38 MAPK after repetitive mild TBI ameliorates immune signaling and behavioral deficit 58 samples shares ameliorate
- GSE316703 Microbiota-Derived Isovalerate Ameliorates Sex-Specific Gut Barrier Dysfunction in Malnutrition [RNA-seq colon epithelium] 50 samples shares ameliorate
- GSE242731 Class switch recombination regulation by extracellular vesicles mediated intercellular epigenomic signaling 48 samples shares combination
- GSE263026 Intravenous immunoglobulin (IVIg) ameliorates disease in a murine model of anti-laminin 332 mucous membrane pemphigoid 46 samples shares ameliorate
- GSE307187 Gene expression following myocardial infarction in mice with Stimulated by retinoic acid gene 6 (Stra6) germline deletion, Vitamin A deficiency, and the combination of both 46 samples shares combination
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.